Skip to main content
Medical information Clinical review pending

Transplant Testing

HLA T B Cell Flow Cytometry Crossmatch Test

The HLA T B Cell Flow Cytometry Crossmatch Test assesses compatibility between organ donors and recipients to help prevent transplant rejection.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Recipient: 2 mL (1 mL min.) serum from 1 SST tube and 4 mL (2 mL min.) whole blood from 1 Green Top (Sodium Heparin) tube. Donor: 3 mL (2 mL min.) whole blood in 3 Green Top (Sodium Heparin) tubes.
Results
Confirm with the laboratory before booking.
Preparation
Collect specimens preferably 48 hours after dialysis. Doctor's prescription on letterhead with stamp and 1 photograph each of recipient and donor is mandatory. A brief history in the Solid Organ Transplant Consent form (Form 33) is also required.
Test priceKSh 20,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the HLA T B Cell Flow Cytometry Crossmatch Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Patients awaiting organ transplantation
  • ✓Individuals with end-stage organ failure
  • ✓Patients with a history of previous transplants
  • ✓Individuals with known sensitization to foreign tissues or blood products
  • ✓Patients with a history of transplant rejection
02

In plain language

What this test helps you understand

This test helps determine the immunological compatibility between a potential organ donor and recipient, predicting the risk of rejection after transplantation.
The HLA T B Cell Flow Cytometry Crossmatch Test is a critical diagnostic tool used in organ transplantation. This test evaluates the compatibility between a donor's and a recipient's immune systems, which is vital for a successful transplant. By identifying potential immunological reactions, it helps healthcare providers make informed decisions about organ matching.

This test specifically measures the presence of antibodies in the recipient's blood that may react against the donor's cells. It uses advanced flow cytometry techniques for a precise evaluation of compatibility.

Individuals who are candidates for organ transplantation should consider this test. It is particularly important for patients with end-stage organ failure, those who have had previous transplants, or individuals with a history of sensitization to foreign tissues or blood products. Significant organ dysfunction or failure, or a history of transplant rejections, may also indicate a need for this test.

Taking this test offers several benefits, including reducing the risk of transplant rejection, enhancing the chances of a successful transplant outcome, providing critical information for planning the transplantation process, and improving patient safety post-transplant.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationCollect specimens preferably 48 hours after dialysis. Doctor's prescription on letterhead with stamp and 1 photograph each of recipient and donor is mandatory. A brief history in the Solid Organ Transplant Consent form (Form 33) is also required.
SampleRecipient: 2 mL (1 mL min.) serum from 1 SST tube and 4 mL (2 mL min.) whole blood from 1 Green Top (Sodium Heparin) tube. Donor: 3 mL (2 mL min.) whole blood in 3 Green Top (Sodium Heparin) tubes.
MethodologyFlow Cytometry
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test detects pre-existing antibodies. It does not predict the development of new antibodies after transplantation. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

This test checks for compatibility between a potential organ donor and recipient by looking for antibodies in the recipient that might react against the donor's cells.
This test is crucial for individuals preparing for organ transplantation, especially those with previous transplants or known sensitization.
A positive result indicates the presence of antibodies that could potentially lead to organ rejection. Your doctor will discuss the implications.
Follow the specific sample collection instructions provided, including timing relative to dialysis and providing required documentation like prescriptions and consent forms.
Results are typically provided within 10-12 days. Discuss the results and their meaning with your transplant specialist.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp